| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 135 | 15.114 | 27.170 | 30.595 | 28.158 | 25.318 | 30.596 | 37.170 | 51.319 | 52.218 |
| Total Income - EUR | 135 | 15.114 | 27.170 | 30.595 | 28.158 | 25.423 | 35.951 | 37.170 | 51.319 | 52.218 |
| Total Expenses - EUR | 0 | 1.887 | 4.415 | 20.583 | 14.800 | 14.308 | 14.875 | 14.130 | 27.602 | 31.810 |
| Gross Profit/Loss - EUR | 135 | 13.226 | 22.755 | 10.013 | 13.358 | 11.116 | 21.075 | 23.040 | 23.717 | 20.408 |
| Net Profit/Loss - EUR | 131 | 12.773 | 21.908 | 9.295 | 12.513 | 10.506 | 20.806 | 22.488 | 23.215 | 18.871 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Echomed Diagnose Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 113 | 75 | 14.397 | 12.258 | 10.218 | 8.255 | 6.342 | 4.627 | 23.651 | 33.590 |
| Current Assets | 180 | 13.162 | 6.259 | 15.984 | 16.399 | 21.159 | 37.678 | 22.328 | 16.974 | 22.484 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 339 | 336 | 63 | 31.953 | 2.290 | 61 | 61 |
| Cash | 180 | 13.162 | 6.259 | 15.645 | 16.062 | 21.077 | 5.725 | 20.038 | 16.913 | 22.423 |
| Shareholders Funds | 176 | 12.826 | 21.960 | 9.347 | 12.563 | 10.556 | 31.128 | 22.537 | 23.263 | 18.919 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 117 | 411 | 18.398 | 39.740 | 28.131 | 21.278 | 12.893 | 4.418 | 17.361 | 37.154 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Echomed Diagnose Srl